INSM SEC Filings: 8-K, 10-Q, S-3 & 424B – Insmed

Financials

TYPE

HEADLINE

FILED AT

10-Q

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Oct 29, 2026

10-Q

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Aug 6, 2026

10-Q

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

May 7, 2026

10-K

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]

Feb 19, 2026

10-Q

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Oct 30, 2025

10-Q

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Aug 7, 2025

News

TYPE

HEADLINE

FILED AT

8-K

Insmed Reports Third-Quarter 2026 Financial Results and Raises Full-Year Revenue Guidance

Oct 29, 2026

8-K

Insmed Appoints Paul Hudson and Utpal Koppikar to Board of Directors

Oct 20, 2026

8-K

Insmed Announces CFO Transition and Reaffirms Full-Year 2026 Financial Guidance

Oct 5, 2026

8-K

Insmed Reports Second-Quarter 2026 Financial Results and Raises Revenue Guidance

Aug 6, 2026

8-K

Insmed Announces Positive 12-Month Data from Open-Label Extension Study of TPIP in PAH Patients

Jul 16, 2026

8-K

Insmed Incorporated Announces Results of 2026 Annual Meeting of Shareholders

May 15, 2026

Prospectus

TYPE

HEADLINE

FILED AT

424B5

Form 424B5 - Prospectus [Rule 424(b)(5)]

Jun 12, 2025

424B5

Form 424B5 - Prospectus [Rule 424(b)(5)]

Jun 11, 2025

424B5

12,621,359 Shares

May 30, 2024

424B5

4,743,475 shares of our common stock reserved for issuance under our Employee Stock Purchase Plan;

May 28, 2024

424B5

4,743,475 shares of our common stock reserved for issuance under our Employee Stock Purchase Plan;

Feb 22, 2024

424B5

13,750,000 Shares

Oct 19, 2022

Registrations

TYPE

HEADLINE

FILED AT

S-3ASR

May 2026 SHELF

May 15, 2026

S-8

Form S-8 - Securities to be offered to employees in employee benefit plans

May 16, 2025

S-8

Form S-8 - Securities to be offered to employees in employee benefit plans

Feb 20, 2025

S-8

Registration

May 14, 2024

S-8

Registration

May 19, 2023

S-3ASR

Up to 27,793 Shares

May 19, 2023

Proxies

TYPE

HEADLINE

FILED AT

DEFA14A

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material

Apr 1, 2026

DEF 14A

Form DEF 14A - Other definitive proxy statements

Apr 1, 2026

DEFA14A

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material

Apr 4, 2025

DEF 14A

Form DEF 14A - Other definitive proxy statements

Apr 4, 2025

DEFA14A

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material

Apr 1, 2024

DEF 14A

Form DEF 14A - Other definitive proxy statements

Apr 1, 2024

Ownerships

TYPE

HEADLINE

FILED AT

144

Form 144 - Report of proposed sale of securities

Nov 3, 2026

Kane Patrick Kevin (Reporting)

Nov 3, 2026

Koppikar Utpal (Reporting)

Oct 20, 2026

Hudson Paul (Reporting)

Oct 20, 2026

Koppikar Utpal (Reporting)

Oct 20, 2026

Hudson Paul (Reporting)

Oct 20, 2026

Other

TYPE

HEADLINE

FILED AT

LETTER

Form UPLOAD - SEC-generated letter

Jan 5, 2021

CORRESP

Form CORRESP - Correspondence

Dec 30, 2020

LETTER

Form UPLOAD - SEC-generated letter

Dec 21, 2020

LETTER

Form UPLOAD - SEC-generated letter

Jan 23, 2020

LETTER

Form UPLOAD - SEC-generated letter

Jan 23, 2020

CORRESP

Form CORRESP - Correspondence

Jan 21, 2020

Insmed Incorporated INSM · SEC Filings